Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
Bradley A. McGregor, MD
With
This research study involves an investigational drug combination not approved by the FDA (the U.S. Food and Drug Administration) for your kidney cancer. The names of the study drugs in this investigational combination are: * Cabozantinib * Nivolumab * Ipilimumab The research study procedures include screening for eligibility, study treatment, participant evaluations and safety follow-up visits, in addition to general health status follow-up after study treatment. It is expected that about 40 people will take part in this research study.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted